Cellebrite DI Ltd.
CLBT- Exchange
- Nasdaq
- Industry
- Services-Prepackaged Software
- SEC CIK
- 0001854587
In the last 90 days, Cellebrite DI Ltd. insiders filed 0 open-market purchases and 6 sales; 204 institutions reported holding it in 13F filings for Q2 2026, worth $1.83B in total; ARK Invest is the only superinvestor holding it.
- Currency
- USD
- Source
- SEC XBRL data (10-K, 10-Q, 20-F, 40-F)
- Updated
- Oct 8, 2026, 2:47 PM ET
Revenue flow, FY2025
Where the revenue went in FY2025, from the income statement below. Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue; hover over a band or a bar for the exact amount.
Income statement
Each column is one fiscal year, newest first.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
| Filing | 20-F | 20-F | 20-F | 20-F | 20-F |
| Reported | – | – | – | – | – |
| Revenue | $475.7M | $401.2M | $325.1M | $270.7M | $246.2M |
| Cost of revenue | $75.2M | $62.6M | $53.2M | $50.7M | $42.6M |
| Gross profit | $400.5M | $338.6M | $271.9M | $219.9M | $203.7M |
| Operating expenses | $334.0M | $281.7M | $238.6M | $218.9M | $189.9M |
| Research and development | $113.9M | $98.4M | $84.4M | $80.6M | $65.5M |
| Selling, general and administrative | $65.3M | $50.9M | $43.4M | $40.9M | $47.9M |
| Operating income | $66.5M | $56.9M | $33.2M | $1.04M | $13.8M |
| Income tax | $12.4M | $7.02M | $5.54M | -$45.0K | $10.9M |
| Net income | $78.3M | -$283.0M | -$81.1M | $120.8M | $71.4M |
| EPS, basic | $0.32 | $-1.35 | $-0.43 | $0.64 | $0.49 |
| EPS, diluted | $0.31 | $-1.35 | $-0.43 | $0.59 | $0.44 |
| Weighted shares, basic | 241.6M | 209.5M | 190.2M | 182.7M | 144.0M |
| Weighted shares, diluted | 249.9M | 209.5M | 190.2M | 195.4M | 161.5M |
| Margins and growth | |||||
| Gross margin | 84.2% | 84.4% | 83.6% | 81.3% | 82.7% |
| Operating margin | 14.0% | 14.2% | 10.2% | 0.4% | 5.6% |
| Net margin | 16.5% | -70.5% | -24.9% | 44.6% | 29.0% |
| Revenue growth, year over year | +18.6% | +23.4% | +20.1% | +9.9% | – |
| Net income growth, year over year | – | – | −167.1% | +69.2% | – |
Balance sheet
Each column is one fiscal year, newest first.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
| Filing | 20-F | 20-F | 20-F | 20-F | 20-F |
| Reported | – | – | – | – | – |
| Cash and equivalents | $124.5M | $191.7M | $189.5M | $87.6M | $146.0M |
| Short-term investments | $151.5M | $101.8M | $38.7M | $44.6M | – |
| Accounts receivable | $105.0M | $82.4M | $77.3M | $78.8M | $67.5M |
| Inventory | $7.60M | $8.94M | $9.94M | $10.2M | $6.51M |
| Total current assets | $575.9M | $567.6M | $422.1M | $295.9M | $273.2M |
| Property, plant and equipment | $22.2M | $17.0M | $15.9M | $17.3M | $16.8M |
| Goodwill | $119.6M | $28.7M | $26.8M | $26.8M | $26.8M |
| Intangible assets | $81.5M | $11.3M | $10.6M | $11.3M | $11.2M |
| Total assets | $938.9M | $690.6M | $532.9M | $403.3M | $339.8M |
| Total current liabilities | $369.7M | $295.5M | $253.8M | $207.8M | $186.6M |
| Total liabilities | $454.5M | $354.5M | $498.7M | $329.4M | $413.1M |
| Shareholders' equity | $484.3M | $336.0M | $34.2M | $73.9M | -$73.3M |
Cash flow statement
Each column is one fiscal year, newest first. Free cash flow is operating cash flow minus capital expenditures.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
| Filing | 20-F | 20-F | 20-F | 20-F | 20-F |
| Reported | – | – | – | – | – |
| Operating cash flow | $173.5M | $132.2M | $102.1M | $20.6M | $36.1M |
| Capital expenditures | $13.2M | $8.57M | $5.23M | $6.90M | $5.11M |
| Free cash flow | $160.3M | $123.6M | $96.8M | $13.7M | $30.9M |
| Depreciation and amortization | $11.9M | $10.6M | $10.0M | $9.19M | $7.01M |
| Stock-based compensation | $44.9M | $30.6M | $19.0M | $13.7M | $6.48M |
| Dividends paid | – | – | $0 | $0 | $100.0M |
| Share buybacks | – | – | – | $0 | $0 |
| Investing cash flow | -$268.3M | -$149.5M | -$22.5M | -$91.2M | $45.2M |
| Financing cash flow | $25.1M | $20.7M | $21.8M | $14.0M | -$68.4M |
| Ratio | |||||
| Stock-based compensation, % of revenue | 9.4% | 7.6% | 5.8% | 5.1% | 2.6% |
Shares outstanding
Common shares outstanding as stated on the cover of each 10-K and 10-Q. The date is the cover date, not the period end; a rising count means dilution.
Notes and known gaps
How these numbers are put together, and what they can't tell you.
- Numbers come from the XBRL data in each period's original 10-K, 10-Q, 20-F or 40-F, or its amendment. They are shown as filed: later filings don't restate earlier periods here.
- Reported is the filing date of the first 8-K with Item 2.02 (results of operations) after the period ended, no later than the 10-Q or 10-K and within 120 days. Companies that release results only in the 10-Q, and foreign companies, which use Form 6-K, have none.
Known gaps
- Foreign companies that file Form 20-F or 40-F have annual statements only: their quarterly results are furnished on Form 6-K, which has no XBRL data.
- EPS and share counts are as reported at the time, not adjusted for later stock splits.
- For ADRs, EPS is per ordinary share, not per ADS (one TSMC ADS is five ordinary shares).
- For banks, revenue may be interest income only, depending on how the bank tags its filings; cost of revenue and gross profit are usually blank.
- Companies with several share classes, such as Berkshire Hathaway, may have no EPS and no cover share count.
- Depreciation and amortization is missing for some companies that report it under their own XBRL tags.